|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2003-5-26
|
|
pubmed:abstractText |
Preconditioning by volatile anesthetics is a promising therapeutic strategy to render myocardial tissue resistant to perioperative ischemia. It was hypothesized that sevoflurane preconditioning would decrease postoperative release of brain natriuretic peptide, a biochemical marker for myocardial dysfunction. In addition, several variables associated with the protective effects of preconditioning were evaluated.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Anesthetics, Inhalation,
http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers,
http://linkedlifedata.com/resource/pubmed/chemical/CST3 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Creatine Kinase,
http://linkedlifedata.com/resource/pubmed/chemical/Cystatin C,
http://linkedlifedata.com/resource/pubmed/chemical/Cystatins,
http://linkedlifedata.com/resource/pubmed/chemical/Methyl Ethers,
http://linkedlifedata.com/resource/pubmed/chemical/Protein Kinase C,
http://linkedlifedata.com/resource/pubmed/chemical/Troponin T,
http://linkedlifedata.com/resource/pubmed/chemical/sevoflurane
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0003-3022
|
|
pubmed:author |
pubmed-author:BestmannLukasL,
pubmed-author:ChassotPierre-GuyPG,
pubmed-author:FrascaroloPhilippeP,
pubmed-author:GarciaCarlosC,
pubmed-author:JulierKarineK,
pubmed-author:PaschThomasT,
pubmed-author:SchmidEdith RER,
pubmed-author:SpahnDonat RDR,
pubmed-author:TurinaMarko IMI,
pubmed-author:ZauggMichaelM,
pubmed-author:ZollingerAndreasA,
pubmed-author:da SilvaRafaelaR,
pubmed-author:von SegesserLudwig KLK
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
98
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1315-27
|
|
pubmed:dateRevised |
2008-11-21
|
|
pubmed:meshHeading |
pubmed-meshheading:12766638-Adult,
pubmed-meshheading:12766638-Aged,
pubmed-meshheading:12766638-Aged, 80 and over,
pubmed-meshheading:12766638-Anesthesia, Inhalation,
pubmed-meshheading:12766638-Anesthetics, Inhalation,
pubmed-meshheading:12766638-Biological Markers,
pubmed-meshheading:12766638-Coronary Artery Bypass,
pubmed-meshheading:12766638-Creatine Kinase,
pubmed-meshheading:12766638-Cystatin C,
pubmed-meshheading:12766638-Cystatins,
pubmed-meshheading:12766638-Electrocardiography, Ambulatory,
pubmed-meshheading:12766638-Female,
pubmed-meshheading:12766638-Heart Diseases,
pubmed-meshheading:12766638-Humans,
pubmed-meshheading:12766638-Immunohistochemistry,
pubmed-meshheading:12766638-Ischemic Preconditioning, Myocardial,
pubmed-meshheading:12766638-Kidney Diseases,
pubmed-meshheading:12766638-Male,
pubmed-meshheading:12766638-Methyl Ethers,
pubmed-meshheading:12766638-Middle Aged,
pubmed-meshheading:12766638-Myocardium,
pubmed-meshheading:12766638-Prognosis,
pubmed-meshheading:12766638-Protein Kinase C,
pubmed-meshheading:12766638-Treatment Outcome,
pubmed-meshheading:12766638-Troponin T
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Preconditioning by sevoflurane decreases biochemical markers for myocardial and renal dysfunction in coronary artery bypass graft surgery: a double-blinded, placebo-controlled, multicenter study.
|
|
pubmed:affiliation |
Department of Anesthesiology, University Hospital Lausanne, Switzerland.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|
